Key Takeaways:
- Whey protein inventories have fallen roughly 50% since 2023
- Prices reached $14 per pound as suppliers sold out through late 2026
- Dairy processing infrastructure built for steady growth cannot scale fast enough
Key Takeaways:

US whey protein inventories have fallen roughly 50% since 2023, pushing prices to $14 per pound as rising consumer demand outstrips dairy processing capacity.
"The market remains extremely tight, with product largely unavailable and buyers continuing to report difficulty securing supply," the US Department of Agriculture said in a June 25 report.
Some suppliers are sold out for the latter half of 2026, according to a separate USDA report from late April. End-of-month inventories have declined by about half since 2023, the data show. Around 70% of Americans now say they are trying to consume more protein, up from 59% four years ago, according to the International Food Information Council.
The shortage reflects a structural mismatch between demand and supply. Dairy processors cannot build whey facilities in isolation — the ingredient is a byproduct of cheesemaking — and most existing plants were designed for steady, predictable growth rather than the sharp spike in protein demand driven by GLP-1 weight-loss drugs and the "protein-maxxing" trend on social media.
Demand Drivers Extend Beyond Fitness Trends
The protein surge has broadened well beyond gym culture. Chipotle launched a "High Protein Menu," Starbucks added a high-protein drink in 2025, and Sweetgreen has offered "protein plates" since 2023. Doritos Protein, which uses casein as its protein ingredient, entered the market as food companies race to reformulate products. "We are going to see an evolution in how food companies access protein," Phil Plourd, a dairy analyst at Ever.Ag, said.
GLP-1 weight-loss drugs are adding another layer of demand. Four major medical societies published joint nutritional guidelines advising patients on these drugs to increase protein intake to preserve lean muscle mass during weight loss. "When you're on GLP-1s and a responder, you see a decline in the desire to eat or drink," said Dr. Fatima Cody Stanford, an obesity medicine physician scientist at Massachusetts General Hospital and a co-author of the guidelines. "We see a decline in lean muscle when patients are on GLP-1s, so we need to ramp up protein."
Infrastructure Constraints Limit Supply Response
The dairy industry cannot quickly add whey processing capacity because the infrastructure is tied to cheesemaking. Converting liquid whey into powder requires specialized filtration equipment, and permitting and construction can take years. "Supply has grown, but it is hard for it to grow as fast as demand," Plourd said.
US dairy producers announced $11 billion in new manufacturing capacity across 19 states last October, according to the International Dairy Foods Association, with plans to grow milk production significantly over the next five years. But the investment cycle takes time. David Steven Jacoby, managing partner at Boston Strategies, estimated that revamping a single plant costs about $15 million, while hundreds of millions of dollars would be needed for large-scale industrial expansion.
Dairy Farmers of America, Saputo, Glanbia, Agropur and Leprino are the companies most likely to invest first given their scale, Jacoby said. Regional processors such as Foremost Farms and Hilmar Cheese could also add capacity to capture market share from cooperatives.
Plourd said the current price spike should moderate over time. "High prices cure high prices," he said. "I don't see it crashing. I think we are likely to see moderation rather than a crash, but it still may take a few years."
This article is for informational purposes only and does not constitute investment advice.